When Every Prescription Is Correct and the Patient Is Still Being Harmed: Understanding Polypharmacy's Invisible Overdose

The Patient Who Did Everything Right

She was 74 years old, a retired school administrator in suburban Ohio, and by any conventional measure, a model patient. She filled her prescriptions on time, took her medications as directed, attended her follow-up appointments, and maintained a detailed list of everything she was prescribed. She had a cardiologist for her atrial fibrillation, a rheumatologist for her osteoarthritis, a primary care physician managing her type 2 diabetes and hypertension, and a neurologist overseeing a mild sleep disorder.

Over three years, her medication count had grown from three to seven. Each prescription was clinically appropriate. Each physician had reviewed her chart. And yet, by the time her daughter brought her to the emergency department following a fall and a brief episode of confusion, she was experiencing the cumulative neurological and cardiovascular effects of drug interactions that no single prescriber had fully mapped.

Her story is not unusual. It is, in fact, representative of a pattern that geriatric pharmacists, hospital physicians, and patient safety researchers have been documenting with increasing urgency for more than a decade.

Polypharmacy by the Numbers

The term polypharmacy formally refers to the concurrent use of five or more medications, though some clinical frameworks set the threshold at four. By either measure, the prevalence among older Americans is striking. Studies published in peer-reviewed journals estimate that between 36 and 42 percent of adults over age 65 in the United States take five or more prescription medications simultaneously. Among adults over 75, that figure climbs further.

The drivers of this accumulation are structural as much as they are medical. Older adults typically manage multiple chronic conditions—hypertension, diabetes, heart disease, arthritis, depression, osteoporosis, and sleep disorders frequently co-occur. Each condition may have its own specialist. Each specialist may prescribe within their area of expertise without complete visibility into what other providers have ordered. Electronic health records have improved information sharing, but they have not eliminated the coordination gaps that allow polypharmacy to escalate unnoticed.

How Dosing Cascades Begin

A dosing cascade is a specific and particularly insidious form of polypharmacy-related harm. It begins when a medication produces a side effect that is misidentified as a new medical condition rather than an adverse drug reaction. A new prescription is then issued to treat that apparent condition—which may itself produce side effects requiring yet another medication.

The cascade can be remarkably difficult to detect from inside it. Each individual prescribing decision appears rational. The symptoms being treated are real. The medications chosen are appropriate for those symptoms. Only when the full regimen is examined as a system—rather than as a collection of individual prescriptions—does the underlying problem become visible.

A commonly cited example involves a patient prescribed a calcium channel blocker for blood pressure who develops ankle swelling as a side effect. The swelling is attributed to early heart failure rather than to the medication, and a diuretic is added. The diuretic causes urinary urgency, which is attributed to an overactive bladder, prompting the addition of an anticholinergic agent. The anticholinergic causes constipation and mild cognitive dulling—symptoms that may then generate additional prescriptions of their own.

At no point in this sequence did any prescriber act negligently. And yet the patient is now taking four medications where one—or a different antihypertensive that does not cause ankle swelling—might have sufficed.

The Cumulative Dose Problem

Beyond cascades, polypharmacy creates a cumulative dosing burden that operates through pharmacological mechanisms that individual prescribers may not fully account for.

Many medications share metabolic pathways. When multiple drugs compete for the same liver enzymes responsible for processing them—particularly the cytochrome P450 enzyme system—blood levels of one or more medications may rise unpredictably. A drug that is well-tolerated at its prescribed dose when taken alone may reach toxic concentrations when a second or third medication slows its metabolism.

The aging body compounds this problem. Kidney and liver function decline with age, reducing the speed at which medications are cleared from the body. Decreased muscle mass and increased body fat alter how drugs are distributed and stored. Reduced albumin levels in older adults affect how much of a protein-bound drug remains pharmacologically active. The result is that a dose calibrated for a 50-year-old body may behave like a significantly higher dose in a 75-year-old body—even if the number on the bottle has never changed.

Central nervous system effects are particularly concerning. Multiple medications with sedating properties—certain antihistamines, sleep aids, muscle relaxants, antidepressants, opioids, and anxiety medications—can produce additive sedation that far exceeds what any single agent would cause. This sedation increases fall risk, impairs driving ability, and can be mistaken for dementia or depression, potentially triggering further prescribing.

Deprescribing: The Medical Practice of Doing Less

The clinical response to polypharmacy-related harm is a process called deprescribing—the systematic, supervised reduction or elimination of medications that are no longer necessary, are causing harm, or whose risks now outweigh their benefits in the context of a patient's current health status and goals.

Deprescribing is not the same as abruptly stopping medications. Many drugs require gradual tapering to avoid withdrawal effects or rebound symptoms. It is a deliberate, medically supervised process that typically begins with a comprehensive medication review.

Geriatric pharmacists and geriatricians are particularly well-equipped to conduct these reviews, though any primary care physician with a full picture of a patient's regimen can initiate the process. Several validated clinical tools—including the Beers Criteria, maintained by the American Geriatrics Society, and the STOPP/START criteria—provide structured frameworks for identifying medications that are potentially inappropriate in older adults.

A Personal Medication Audit Checklist

Patients and caregivers do not need to wait for a specialist referral to begin identifying polypharmacy risk. The following checklist is designed to support a productive conversation with a physician or pharmacist.

Compile a complete medication inventory. Include every prescription medication, over-the-counter drug, vitamin, herbal supplement, and topical preparation. Many patients undercount because they do not consider supplements or topicals to be medications, but these can interact with prescriptions in clinically significant ways.

Note the prescribing physician for each medication. If multiple providers are prescribing, identify whether any single provider has a complete view of the full regimen.

Flag medications that have been taken for more than two years without a formal review. Long-term medications warrant periodic reassessment, particularly as health status changes.

Identify any medication that was started in response to a symptom that appeared after another medication was added. This is the hallmark pattern of a dosing cascade.

Ask your pharmacist to run a drug interaction check on the complete list. This service is available at most retail and mail-order pharmacies and can surface interactions that may not have been identified at the point of prescribing.

Request a medication reconciliation appointment with your primary care physician. This is a formal review of all active prescriptions with the explicit goal of identifying what can be reduced, consolidated, or eliminated.

Ask about each medication: What is this treating? Is it still needed? What would happen if we stopped it? These questions are clinically appropriate and are not challenges to the prescriber's judgment. They are the foundation of informed, collaborative care.

The Goal Is Not Fewer Medications—It Is the Right Medications

Polypharmacy is not inherently a failure of medicine. For many patients, multiple concurrent medications are clinically necessary and appropriately managed. The failure occurs when the cumulative picture is never assembled, when no one provider owns the full view, and when a patient's deteriorating function is attributed to aging rather than to the drugs intended to support their health.

The patients most likely to benefit from a systematic medication review are those taking five or more medications, those who have seen their regimen grow substantially over the past two to three years, those experiencing unexplained fatigue, confusion, falls, or gastrointestinal symptoms, and those who have recently changed primary care providers without a formal handoff of medication history.

For those patients, a comprehensive medication audit is not a bureaucratic exercise. It may be among the most consequential health decisions they make.